Alpha 2.0
Login Register
» Authors » B Barroso

B Barroso

Explore the profile of B Barroso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 257
Followers 0
Related Specialties
Allergy & Immunology
Neurology
General Surgery
Top 10 Co-Authors
J Sastre
D Betancor
M Valverde-Monge
A Gomez-Lopez
V Del Pozo
J M Olaguibel
J M Rodrigo-Munoz
I Bobolea
X Munoz
F J Gonzalez-Barcala
Published In
J Investig Allergol Clin Immunol
Rev Neurol (Paris)
Presse Med
Neurology
J Neurol Neurosurg Psychiatry
Affiliations
Soon will be listed here.
Recent Articles
1.
Revisited the Impact of Misdiagnosed Drug Hypersensitivity in Hospitalized Patients: A 10-Year Perspective
Bernaola J, Otal-Buesa M, Barroso B, Valverde-Monge M, Sastre J
J Investig Allergol Clin Immunol . 2025 Mar; PMID: 40029192
No abstract available.
2.
Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project
Rial M, Betancor D, Canas J, Olaguibel J, Rodrigo-Munoz J, Alvarez-Puebla M, et al.
J Investig Allergol Clin Immunol . 2024 Nov; 35(1):53-55. PMID: 39589454
No abstract available.
3.
Are Biosimilars of Biologics the Same as the Reference Drug in Terms of Allergy? Selective Allergy to Tocilizumab Biosimilar
Betancor D, Gomez-Lopez A, Barroso B, Valverde-Monge M, Canas J, Rodrigo-Munoz J, et al.
J Investig Allergol Clin Immunol . 2024 Nov; 35(1):68-69. PMID: 39535898
No abstract available.
4.
Hypersensitivity to the CGRP Inhibitor Monoclonal Antibodies Galcanezumab, Erenumab, and Fremanezumab With Tolerance to Eptinezumab
Barroso B, Rodrigo-Munoz J, Gil-Martinez M, Del Pozo V, Rodriguez-Vico J, Betancor D, et al.
J Investig Allergol Clin Immunol . 2024 Oct; 34(5):348-349. PMID: 39441051
No abstract available.
5.
Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort
Betancor D, Otal M, Olaguibel J, Rodrigo-Munoz J, Alvarez Puebla M, Arismendi E, et al.
J Investig Allergol Clin Immunol . 2024 Jun; 34(3):192-195. PMID: 38888581
No abstract available.
6.
Hypersensitivity Reactions to the GLP-1 Receptor Agonists Liraglutide and Semaglutide: A Case Series
Barroso B, Gomez-Lopez A, Valverde-Monge M, Betancor D, de Las Heras M, Sastre J
J Investig Allergol Clin Immunol . 2024 Apr; 34(2):133-135. PMID: 38639450
No abstract available.
7.
Effect of Different Therapeutic Strategies on Olfactory Outcomes in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review
Alobid I, Barroso B, Calvo C, Ferrario M, Sastre J
J Investig Allergol Clin Immunol . 2024 Jan; 34(4):218-224. PMID: 38174981
Introduction: Olfactory impairment is one of the cardinal symptoms of chronic rhinosinusitis with nasal polyps (CRSwNP). However, the effect of currently available therapeutic options on the recovery of the sense...
8.
Nonasthmatic Eosinophilic Bronchitis: A Systematic Review of Current Treatment Options
Betancor D, Valverde-Monge M, Barroso B, Gomez-Lopez A, Sastre J
J Investig Allergol Clin Immunol . 2023 Dec; 34(5):282-292. PMID: 38113129
Nonasthmatic eosinophilic bronchitis is characterized by persistent dry or barely productive cough and bronchial eosinophilia without airway obstruction or bronchial hyperreactivity. It is primarily a chronic disease, in which some...
9.
Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies"
Barroso B, Valverde-Monge M, Alobid I, Olaguibel J, Rial M, Quirce S, et al.
J Investig Allergol Clin Immunol . 2023 Dec; 33(6):503-504. PMID: 38095497
No abstract available.
10.
Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review
Barroso B, Valverde-Monge M, Betancor D, Gomez-Lopez A, Villalobos-Vilda C, Gonzalez-Cano B, et al.
J Investig Allergol Clin Immunol . 2023 Sep; 33(6):419-430. PMID: 37669083
Background: Impairment of smell is more commonly related to chronic rhinosinusitis with nasal polyps (CRSwNP) than without, especially when asthma and/or NSAID-exacerbated respiratory disease and type 2 inflammation are also...